CRISPR-Cas-Mediated Phage Resistance Enhances Horizontal Gene Transfer by Transduction

por Watson, Bridget N. J., Staals, Raymond H. J., Fineran, Peter C.
Publicado 2018

Type I-F CRISPR-Cas resistance against virulent phages results in abortive infection and provides population-level immunity

por Watson, Bridget N. J., Vercoe, Reuben B., Salmond, George P. C., Westra, Edze R., Staals, Raymond H. J, Fineran, Peter C.
Publicado 2019

Decolonizing drug-resistant E. coli with phage and probiotics: breaking the frequency-dependent dominance of residents

por Forsyth, Jessica H., Barron, Natalie L., Scott, Lucy, Watson, Bridget N. J., Chisnall, Matthew A. W., Meaden, Sean, van Houte, Stineke, Raymond, Ben
Publicado 2023

Targeting of temperate phages drives loss of type I CRISPR-Cas systems

por Rollie, Clare, Chevallereau, Anne, Watson, Bridget N.J., Chyou, Te-yuan, Fradet, Olivier, McLeod, Isobel, Fineran, Peter C., Brown, Chris M., Gandon, Sylvain, Westra, Edze R.
Publicado 2020

Priming in the Type I-F CRISPR-Cas system triggers strand-independent spacer acquisition, bi-directionally from the primed protospacer

por Richter, Corinna, Dy, Ron L., McKenzie, Rebecca E., Watson, Bridget N.J., Taylor, Corinda, Chang, James T., McNeil, Matthew B., Staals, Raymond H.J., Fineran, Peter C.
Publicado 2014